Tess van Stekelenburg advances innovation at Lux Capital, focusing on biological design and AI-driven generative biology. With research experience in computational neuroscience at Oxford and bioengineering at UCL, she bridges cutting-edge biology and technology. Her insights into AI applications in protein and DNA design underscore her expertise at the forefront of bioengineering and synthetic biology.

‌